hotspot -WSS

hotspot

author：knowledge 2025-09-29 16:25:35 - browse：1413

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

hotspot

WSS

Prosthetic arm enables patients to feel the objects they grip

Weight loss drug costs may need more research, senator suggests

Childhood cancer progress stalls for Black, Hispanic kids: Report

Lab trade group sues FDA to halt regulation of lab

Weight loss drug costs may need more research, senator suggests

Akili, maker of video game for ADHD, to be acquired for 34 million

focus

hotspot

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Hollywood unions extend contract negotiations for actors

What will save rural psychiatry services? Higher Medicaid payments

Alkermes shareholders re

David Sabatini, ex

Alkermes shareholders re

Health insurers say they are turning to AI to cut costs, improve care

Medical leaders decry Supreme Court decision on affirmative action

David Sabatini, ex

knowledge

Focused ultrasound for uterine fibroids: an uphill battle

Surge of respiratory disease in China has likely explanation

Morphosys mixed study results for blood cancer drug

FDA's Woodcock to retire early next year

Latest bird flu infection made farmworker sicker than earlier cases

First Opinion Podcast: What happens when kids become caregivers?

knowledge

focus

Wikipedia

focus